EUS-FNA for Patients With Antithrombotic Agents

The purpose of this study to evaluate a safety of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for patients with antithrombotic agents.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solid Tumor

Sex eligibility

All sexes

Study type

Observational

Primary location

Hokkaido University Graduate School of Medicine

Sapporo, 0808648, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Undergo EUS-FNA
take antithrombotic agents

Exclusion criteria

Cystic lesion

Treatment and study plan

Primary outcomes

Patients who suffered bleeding complication

Time frame: One week

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Hokkaido Pancreatobiliary Endoscopic Intervention Study Group

Network

Collaborators

Hokkaido University Hospital

Registry information

Official study title

Safety of Endoscopic Ultrasound-guided Fine Needle Aspiration for Patients With Antithrombotic Agents

Important dates

Study start: 2012
Primary completion: 2015
First posted: Feb 26, 2013
Registry last updated: Feb 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed